Emerging drugs for the treatment of pancreatic cancer

Author： Van Laethem Jean-Luc   Marechal Raphael  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.2, 2007-05, pp. : 301-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs in the treatment of pancreatic cancer

By Mahalingam Devalingam   Kelly Kevin R   Swords Ronan T   Carew Jennifer   Nawrocki Steffan T   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 311-328

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in pancreatic cancer

By Ducreux Michel   Boige Valérie   Malka David  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 73-89

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in the treatment of advanced gastric cancer

By Tetzlaff Eric D   Cen Putao   Ajani Jaffer A  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the treatment of metastatic renal cancer

By Samlowski Wolfram E   Vogelzang Nicholas J  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 605-618

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the management of cancer treatment induced bone loss

By Bertoldo Francesco   Pancheri Serena   Zenari Sonia   Boldini Stefania  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 323-342

Informa Healthcare

Access to resources Recommend Favorite